[{"Assets_0_Q1_USD":33083000000.0,"EarningsPerShareBasic_1_Q1_USD":0.91,"EarningsPerShareDiluted_1_Q1_USD":0.91,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":1175000000.0,"NetIncomeLoss_1_Q1_USD":1486000000.0,"StockholdersEquity_0_Q1_USD":12793000000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":1640000000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":1633000000.0,"Ticker":"BMY","CIK":"14272","name":"BRISTOL MYERS SQUIBB CO","OfficialName":"Bristol-Myers Squibb Company Common Stock","form":"10-Q","period":"20180331","fy":"2018.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"162365472986.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NYSE","SP500":"SP500","filed":"20180426"}]